Evidence map›Paper›PMID 36879899›Full record

ArticleNAR genomics and bioinformatics2023

TiSA: TimeSeriesAnalysis-a pipeline for the analysis of longitudinal transcriptomics data.

Yohan Lefol, Tom Korfage, Robin Mjelle, Christian Prebensen, Torben Lüders, Bruno Müller, Hans Krokan, Antonio Sarno, Lene Alsøe, CONSORTIUM LEMONAID and 4 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Regulation of lineage reprogramming by dynamic chromatin SUMOylation.Cellular and molecular life sciences : CMLS · 2026
    Article
  4. Article
  5. Article
  6. Longitudinal omics data analysis: approaches and applications.Computational and structural biotechnology journal · 2026
    Review
  7. Article
  8. Article
  9. Serotonin Mitigates ColdStress-Induced Damage inInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Article
  12. Transcriptomic analysis revealsOncology letters · 2024
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yohan LefolInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.
Tom KorfageCytura Therapeutics BV, Kloosterstraat 9, Oss 5349AB, The Netherlands.
Robin MjelleDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Erling Skjalgsons gate 1, Trondheim 7491, Norway.
Christian PrebensenInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.
Torben LüdersInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.
Bruno MüllerMicrosynth AG, Schützenstrasse 15, Balgach CH-9436, Switzerland.
Hans KrokanDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Erling Skjalgsons gate 1, Trondheim 7491, Norway.
Antonio SarnoDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Erling Skjalgsons gate 1, Trondheim 7491, Norway.
Lene AlsøeInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.
CONSORTIUM LEMONAID
Jan-Erik BerdalInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.
Pål SætromDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Erling Skjalgsons gate 1, Trondheim 7491, Norway.ORCID https://orcid.org/0000-0001-8142-7441
Hilde NilsenInstitute of Clinical Medicine, University of Oslo, PO Box 1171, Blindern 0318, Norway.ORCID https://orcid.org/0000-0003-2115-2663
Diana DomanskaDepartment of Microbiology, University of Oslo, Rikshospitalet, Oslo 0424, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improved transcriptomic sequencing technologies now make it possible to perform longitudinal experiments, thus generating a large amount of data. Currently, there are no dedicated or comprehensive methods for the analysis of these experiments. In this article, we describe our TimeSeries Analysis pipeline (TiSA) which combines differential gene expression, clustering based on recursive thresholding, and a functional enrichment analysis. Differential gene expression is performed for both the temporal and conditional axes. Clustering is performed on the identified differentially expressed genes, with each cluster being evaluated using a functional enrichment analysis. We show that TiSA can be used to analyse longitudinal transcriptomic data from both microarrays and RNA-seq, as well as small, large, and/or datasets with missing data points. The tested datasets ranged in complexity, some originating from cell lines while another was from a longitudinal experiment of severity in COVID-19 patients. We have also included custom figures to aid with the biological interpretation of the data, these plots include Principal Component Analyses, Multi Dimensional Scaling plots, functional enrichment dotplots, trajectory plots, and complex heatmaps showing the broad overview of results. To date, TiSA is the first pipeline to provide an easy solution to the analysis of longitudinal transcriptomics experiments.

Identifiers

PMID36879899
PMCPMC9985321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.